Clinical update on COVID-19 for the emergency and critical care clinician: Medical management
- 26 March 2022
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 56, 158-170
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Coronavirus Disease (COVID-19): A primer for emergency physiciansThe American Journal of Emergency Medicine, 2021
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroAntiviral Research, 2020
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trialBMJ, 2020
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid reviewCochrane Database of Systematic Reviews, 2020
- Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19)BioScience Trends, 2020
- Effective treatment of severe COVID-19 patients with tocilizumabProceedings of the National Academy of Sciences, 2020
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent PlasmaJAMA, 2020
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionJAMA Network Open, 2020
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal modelCell Research, 2012